
Woxsen University Partners with IBM for Industry Calibrated Academic Programs
HYDERABAD, India , June 9, 2025 /PRNewswire/ — Woxsen University has entered into a strategic MoU with IBM India Private Limited, an academic-industry collaboration poised to reshape the way business and technology education converge.
The five-year alliance spans the School of Business and School of Technology, with direct impact on the MBA (Business Analytics) and BBA (Data Science & Artificial Intelligence) programs. It introduces a unified learning framework where students across disciplines engage with enterprise-level tools and frameworks aligned with global business standards.
'Our partnership with IBM is not an add-on. It is a structural shift in how we envision higher education. By embedding enterprise-grade tools and certifications into the DNA of our curriculum, we are placing Woxsen students on the same technological footing as professionals in Fortune 500 companies. This alliance breaks down the traditional silos between business and technology education, enabling a business analyst to speak the language of AI and a data scientist to understand market strategy. This collaboration ensures our graduates are ready from day one and are equipped to lead with technological fluency, strategic sharpness and global agility.' — Dr. Raul Villamarin Rodriguez , Vice President, Woxsen University.
Through this collaboration, students gain structured access to IBM's suite of technologies, including artificial intelligence, blockchain, and advanced analytics platforms. Each participant receives globally acknowledged IBM certifications, embedded directly into academic delivery.
IBM's subject matter experts will engage closely with Woxsen's faculty to co-deliver training grounded in current industry practices and use cases. The pedagogical approach emphasizes applied learning, ensuring students build competencies that hold relevance from the outset of their careers.
The partnership further facilitates an integrated innovation environment. Students from business analytics, data science, and artificial intelligence work in interdisciplinary cohorts, reflecting the collaborative dynamics of modern enterprises. This environment enables learners to build strategic insight alongside technical acumen, equipping them to contribute meaningfully to technology led initiatives.
With curriculum co-developed alongside IBM and aligned with industry frameworks, graduates transition into the workforce with minimal adjustment. The alliance also strengthens career trajectories through IBM's extensive professional network, creating pathways for internships and early placements.
This initiative reflects the alignment of Woxsen's international recognition with rankings from QS, Bloomberg, and IIRF and IBM's longstanding presence at the intersection of business and technology. The partnership brings together two institutions committed to cultivating leaders who understand both commercial imperatives and technological evolution.
The MoU introduces a dynamic structure for continuous academic enrichment, responsive to technological change and market demand. In an increasingly complex global business environment, this collaboration signals Woxsen's intent to prepare its students not only to participate in the digital economy, but to shape it.
About Woxsen University, Hyderabad :
Woxsen University, located in Hyderabad , is one of the first private universities in the state of Telangana, India . Renowned for its 200-acre state-of-the-art campus and infrastructure, Woxsen University offers new-age, disruptive programs in the fields of Business, Technology, Arts & Design, Architecture, Law, and Liberal Arts & Humanities. Woxsen also houses Asia's largest Sports Infrastructure, spread over 60 acres. With 170+ Global Partner Universities and a strong industry connect, Woxsen is recognized as one of the top universities for Academic Excellence and Global Edge. Woxsen has also secured the QS Business Masters World Ranking 2025, Rank #9 All India, Top 100 B -Schools by Times B-School Ranking 2025, Rank #6, Asia Pacific , Bloomberg Best B-School, and features in India's Best B-Schools beyond IIMs by Dalal Street Investment Journal 2025, in 4th consecutive year. Woxsen is ranked as one of the Top Professional Colleges in India by Outlook I-CARE for its undergraduate programs, securing All India Rank 12 among the Top 130 BBA Private Institutes, All India Rank 20 among the Top 160 B .Tech Private Institutes, All India Rank 3 among the Top 25 Design Private Institutes, and All India Rank 3 among the Top 30 B .Arch Private Institutes.
Photo: https://mma.prnewswire.com/media/2706085/WOXSEN_IBM_1.jpgPhoto: https://mma.prnewswire.com/media/2706086/WOXSEN_IBM_2.jpg
Logo: https://mma.prnewswire.com/media/1771070/5359447/Woxsen_University_Logo.jpg

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Cloud Range to Showcase Cutting-Edge Cybersecurity Simulations at 2025 Gartner Security & Risk Management Summit
Industry Leader Highlights Innovations in Cyber Preparedness Training NASHVILLE, Tenn., June 09, 2025--(BUSINESS WIRE)--Cloud Range, the leading enterprise cyber range platform for reducing detection and response times thereby reducing cyber risk, today announced it will showcase its latest innovations in cyber readiness and pre-emptive preparedness at the 2025 Gartner Security & Risk Management Summit, June 9–11 in National Harbor, MD. At the summit, Cloud Range will demonstrate its latest advancements, including the award-winning Range365™ platform—a fully managed, cloud-based cyber range with customizable IT and OT/ICS environments. Range365 strengthens security teams to engage in realistic attack scenarios, directly reducing cyber risk. Additionally, Cloud Range will showcase its Performance Portal, a comprehensive learning management system (LMS) providing detailed analytics on individual and team performance, enabling targeted, continuous skill development aligned to organizational needs. "The Gartner Summit is a pivotal event that brings together the brightest minds in cybersecurity," said Debbie Gordon, CEO and Founder of Cloud Range. "As cyber threats become increasingly sophisticated, it's clear that tools and tech stacks alone are not enough. From global enterprises to top universities, organizations must recognize that people—not just technology—are at the core of cyber defense. Our mission is to ensure SOC and incident response teams are always ready through immersive, real-world training programs that provide hands-on experience, build confidence, and help ensure resilience. Our presence at the summit underscores our commitment to advancing cyber defense capabilities across industries." Cloud Range's innovative approach has garnered significant recognition, including the 2025 SC Award for Best IT Security-Related Training Program and the 2025 Global InfoSec Award for Visionary Cybersecurity Training. These accolades and others reflect the company's dedication to providing cutting-edge solutions that address the evolving needs of cybersecurity professionals. Beyond enterprise solutions, Cloud Range is actively involved in shaping the future of cybersecurity education. Through collaborations with initiatives like IBM's Cyber Campus and partnerships with organizations such as Cyviz, Cloud Range is integrating its simulation technology into academic curricula, providing students with practical, real-world skills and experience to bridge the gap between theoretical knowledge and real-world application. It's a true redefinition of the student journey. For more information about Cloud Range's offerings or to schedule a demonstration at the Gartner Security & Risk Management Summit, visit: About Cloud Range Cloud Range is the first cyber Range-as-a-Service, delivering fully customizable cyberattack simulation training to prepare security teams for real-world threats. Trusted by enterprise SOCs, MSSPs, government agencies, higher education institutions, utilities, and critical infrastructure, Cloud Range helps organizations accelerate cyber defense skills and reduce risk. With Cloud Range's immersive, on-demand platform, customers can train teams, assess talent, onboard new hires, and upskill cybersecurity professionals—without needing costly physical labs or red teams. Recent recognition includes the 2025 SC Award for Best IT Security Training Program, the 2025 Global InfoSec Award for Visionary in Cybersecurity Training, the CISO Choice Award, and more. Stay ahead of threats with hands-on cyber readiness. Explore Cloud Range at View source version on Contacts Media Contact Leslie KesselringKesselring Communications for Cloud Rangeleslie@ 503-358-1012 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
36 minutes ago
- Business Wire
Cloud Range to Showcase Cutting-Edge Cybersecurity Simulations at 2025 Gartner Security & Risk Management Summit
NASHVILLE, Tenn.--(BUSINESS WIRE)-- Cloud Range, the leading enterprise cyber range platform for reducing detection and response times thereby reducing cyber risk, today announced it will showcase its latest innovations in cyber readiness and pre-emptive preparedness at the 2025 Gartner Security & Risk Management Summit, June 9–11 in National Harbor, MD. At the summit, Cloud Range will demonstrate its latest advancements, including the award-winning Range365™ platform—a fully managed, cloud-based cyber range with customizable IT and OT/ICS environments. Range365 strengthens security teams to engage in realistic attack scenarios, directly reducing cyber risk. Additionally, Cloud Range will showcase its Performance Portal, a comprehensive learning management system (LMS) providing detailed analytics on individual and team performance, enabling targeted, continuous skill development aligned to organizational needs. 'The Gartner Summit is a pivotal event that brings together the brightest minds in cybersecurity,' said Debbie Gordon, CEO and Founder of Cloud Range. 'As cyber threats become increasingly sophisticated, it's clear that tools and tech stacks alone are not enough. From global enterprises to top universities, organizations must recognize that people—not just technology—are at the core of cyber defense. Our mission is to ensure SOC and incident response teams are always ready through immersive, real-world training programs that provide hands-on experience, build confidence, and help ensure resilience. Our presence at the summit underscores our commitment to advancing cyber defense capabilities across industries.' Cloud Range's innovative approach has garnered significant recognition, including the 2025 SC Award for Best IT Security-Related Training Program and the 2025 Global InfoSec Award for Visionary Cybersecurity Training. These accolades and others reflect the company's dedication to providing cutting-edge solutions that address the evolving needs of cybersecurity professionals. Beyond enterprise solutions, Cloud Range is actively involved in shaping the future of cybersecurity education. Through collaborations with initiatives like IBM's Cyber Campus and partnerships with organizations such as Cyviz, Cloud Range is integrating its simulation technology into academic curricula, providing students with practical, real-world skills and experience to bridge the gap between theoretical knowledge and real-world application. It's a true redefinition of the student journey. For more information about Cloud Range's offerings or to schedule a demonstration at the Gartner Security & Risk Management Summit, visit: About Cloud Range Cloud Range is the first cyber Range-as-a-Service, delivering fully customizable cyberattack simulation training to prepare security teams for real-world threats. Trusted by enterprise SOCs, MSSPs, government agencies, higher education institutions, utilities, and critical infrastructure, Cloud Range helps organizations accelerate cyber defense skills and reduce risk. With Cloud Range's immersive, on-demand platform, customers can train teams, assess talent, onboard new hires, and upskill cybersecurity professionals—without needing costly physical labs or red teams. Recent recognition includes the 2025 SC Award for Best IT Security Training Program, the 2025 Global InfoSec Award for Visionary in Cybersecurity Training, the CISO Choice Award, and more. Stay ahead of threats with hands-on cyber readiness. Explore Cloud Range at
Yahoo
2 hours ago
- Yahoo
Abcuro Appoints Courtney Cupples as Chief Commercial Officer
Ms. Cupples brings extensive global commercial leadership and rare disease product launch experience NEWTON, Mass., June 09, 2025--(BUSINESS WIRE)--Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced the appointment of Courtney Cupples as Chief Commercial Officer (CCO). Ms. Cupples brings more than 25 years of global commercial leadership and rare disease product launch experience. "We are excited to welcome Courtney to Abcuro as a key member of the leadership team as we prepare for the potential commercialization of our lead asset, ulviprubart, currently in Phase 3 clinical development for the potential treatment of inclusion body myositis (IBM), a rare and debilitating muscle disease," said Alex Martin, Chief Executive Officer. "Courtney has extensive expertise in global commercial strategy, commercial team leadership, and has worked on several successful orphan drug launches." Ms. Cupples most recently served as Chief Commercial Officer for Priovant Therapeutics, where she led commercial launch preparation for the company's oral small molecule, brepocitinib, currently in development for the potential treatment of severe autoimmune diseases. She began her career at Genzyme Corporation where she served in various commercial roles for over 11 years, driving expansion of the company's enzyme replacement therapy business in Latin America. She then spent nine years at Alexion Pharmaceuticals where she led the launch of Soliris® (eculizumab) in Latin America, served as leader of the $1 billion global franchise for the atypical hemolytic uremic syndrome (aHUS) indication for (Soliris®) and led the global metabolic disease franchise for Strensiq® (asfotase alfa) and Kanuma® (sebelipase alfa). Following Alexion, Ms. Cupples joined Biohaven Pharmaceuticals to lead commercial strategic planning for the company's clinical-stage rare disease portfolio focused primarily on neuromuscular conditions. Ms. Cupples holds a Bachelor of Arts in Sociology & Anthropology from Swarthmore College. "I am thrilled to join Abcuro's team of innovative, experienced and passionate individuals whose collective commitment to turning groundbreaking science into a potentially life-transforming treatment for people with a devastating disease like IBM is truly inspiring," said Ms. Cupples. "I look forward to partnering with this talented team as we move into this exciting next chapter together, including initial data from the MUSCLE study expected in the first half of 2026." About Ulviprubart Ulviprubart (ABC008) is a first-in-class anti-KLRG1 antibody product candidate capable of selectively depleting highly cytotoxic T cells, while sparing naïve, regulatory and central memory T cells. Ulviprubart is designed to treat diseases mediated by highly cytotoxic T cells, including the autoimmune muscle disease inclusion body myositis (IBM) and T cell large granular lymphocytic leukemia (T-LGLL). The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have each granted orphan drug designation to ulviprubart for the treatment of IBM. About Inclusion Body Myositis (IBM) IBM is a rare and debilitating autoimmune disease in which highly cytotoxic T cells chronically attack muscle tissue leading to progressive weakness and limb muscle atrophy. People living with IBM progressively lose muscle function, including loss of grip, dexterity and mobility. There are currently no available disease-modifying treatment options and no cure for IBM. Based on published epidemiology literature, it is estimated that there are more than 50,000 people with IBM across the US and Europe. About Abcuro Abcuro is a clinical stage biotechnology company developing first-in-class immunotherapies for the treatment of autoimmune diseases and cancer through precise modulation of highly cytotoxic T cells. The company's lead program is ulviprubart (ABC008) and is currently in clinical trials for inclusion body myositis (IBM) and T cell large granular lymphocytic leukemia. For more information, visit us on LinkedIn and at View source version on Contacts Matthew DeYoungInvestor Relations and MediaArgot Partnersabcuro@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data